TECX Earnings & Financial Statements
Tectonic Therapeutic, Inc.
$21.34
+$0.38(+1.81%)
38
Overall
60
Value
18
Tech
36
Quality
Market Cap
$409.75M
Volume
50.94K
52W Range
$15.45 - $39.53
Target Price
$76.63
TECX earnings and financial statements: Tectonic Therapeutic, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TECX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $77.0K | $23.0K | - |
| Cost of revenue | - | - | - | $2.97M | - |
| Operating income | -$84.04M | -$58.02M | -$44.65M | -$105.43M | -$118.84M |
| EBITDA | -$69.41M | -$55.81M | -$55.74M | -$103.99M | -$117.44M |
| Net income | -$74.20M | -$58.00M | -$42.80M | -$105.89M | -$119.13M |
| EPS (diluted) | $-4.05 | $-6.83 | $3.24 | $-2.42 | $-2.78 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $261.04M | $152.91M | $39.40M | $103.95M | $203.84M |
| Total liabilities | $9.71M | $12.13M | $43.41M | $28.58M | $34.36M |
| Shareholders’ equity | $251.33M | $140.78M | -$84.64M | $75.37M | $169.48M |
| Cash and equivalents | $253.80M | $141.24M | $28.77M | $92.56M | $189.57M |
| Long-term debt | $43.0K | $519.0K | $2.52M | $15.46M | $14.95M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$60.08M | -$59.08M | -$40.68M | -$27.64M | -$12.45M |
| Capital expenditure | -$138.0K | -$156.0K | -$279.0K | -$2.09M | -$2.12M |
| Free cash flow | -$60.29M | -$59.24M | -$40.96M | -$29.73M | -$14.58M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TECX | $21.34 | +1.8% | 50.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tectonic Therapeutic, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW